CytomX Therapeutics Statistics
Total Valuation
CTMX has a market cap or net worth of $376.00 million. The enterprise value is $224.80 million.
Important Dates
The next estimated earnings date is Thursday, November 6, 2025, after market close.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CTMX has 164.91 million shares outstanding. The number of shares has increased by 17.52% in one year.
| Current Share Class | 164.91M |
| Shares Outstanding | 164.91M |
| Shares Change (YoY) | +17.52% |
| Shares Change (QoQ) | +48.11% |
| Owned by Insiders (%) | 0.60% |
| Owned by Institutions (%) | 63.30% |
| Float | 120.28M |
Valuation Ratios
The trailing PE ratio is 4.66.
| PE Ratio | 4.66 |
| Forward PE | n/a |
| PS Ratio | 1.56 |
| Forward PS | 8.83 |
| PB Ratio | 3.14 |
| P/TBV Ratio | 3.17 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 4.68 |
| EV / Sales | 1.59 |
| EV / EBITDA | 5.03 |
| EV / EBIT | 5.21 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.20, with a Debt / Equity ratio of 0.06.
| Current Ratio | 4.20 |
| Quick Ratio | 4.08 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | 0.14 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 108.21% and return on invested capital (ROIC) is 50.23%.
| Return on Equity (ROE) | 108.21% |
| Return on Assets (ROA) | 16.13% |
| Return on Invested Capital (ROIC) | 50.23% |
| Return on Capital Employed (ROCE) | 31.75% |
| Revenue Per Employee | $1.17M |
| Profits Per Employee | $396,554 |
| Employee Count | 121 |
| Asset Turnover | 0.84 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CTMX has paid $249,000 in taxes.
| Income Tax | 249,000 |
| Effective Tax Rate | 0.52% |
Stock Price Statistics
The stock price has increased by +82.40% in the last 52 weeks. The beta is 2.17, so CTMX's price volatility has been higher than the market average.
| Beta (5Y) | 2.17 |
| 52-Week Price Change | +82.40% |
| 50-Day Moving Average | 2.24 |
| 200-Day Moving Average | 1.42 |
| Relative Strength Index (RSI) | 57.29 |
| Average Volume (20 Days) | 4,051,062 |
Short Selling Information
The latest short interest is 25.14 million, so 15.24% of the outstanding shares have been sold short.
| Short Interest | 25.14M |
| Short Previous Month | 23.96M |
| Short % of Shares Out | 15.24% |
| Short % of Float | 20.90% |
| Short Ratio (days to cover) | 9.14 |
Income Statement
In the last 12 months, CTMX had revenue of $141.10 million and earned $47.98 million in profits. Earnings per share was $0.49.
| Revenue | 141.10M |
| Gross Profit | 141.10M |
| Operating Income | 43.13M |
| Pretax Income | 15.08M |
| Net Income | 47.98M |
| EBITDA | 44.70M |
| EBIT | 43.13M |
| Earnings Per Share (EPS) | $0.49 |
Full Income StatementBalance Sheet
The company has $158.09 million in cash and $6.89 million in debt, giving a net cash position of $151.20 million or $0.92 per share.
| Cash & Cash Equivalents | 158.09M |
| Total Debt | 6.89M |
| Net Cash | 151.20M |
| Net Cash Per Share | $0.92 |
| Equity (Book Value) | 119.91M |
| Book Value Per Share | 0.73 |
| Working Capital | 125.40M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$77.43 million and capital expenditures -$245,000, giving a free cash flow of -$77.68 million.
| Operating Cash Flow | -77.43M |
| Capital Expenditures | -245,000 |
| Free Cash Flow | -77.68M |
| FCF Per Share | -$0.47 |
Full Cash Flow StatementMargins
Gross margin is 100.00%, with operating and profit margins of 30.56% and 34.01%.
| Gross Margin | 100.00% |
| Operating Margin | 30.56% |
| Pretax Margin | 34.18% |
| Profit Margin | 34.01% |
| EBITDA Margin | 31.68% |
| EBIT Margin | 30.56% |
| FCF Margin | n/a |
Dividends & Yields
CTMX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -17.52% |
| Shareholder Yield | n/a |
| Earnings Yield | 12.76% |
| FCF Yield | -20.66% |
Analyst Forecast
The average price target for CTMX is $5.67, which is 148.68% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $5.67 |
| Price Target Difference | 148.68% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | -0.65% |
| EPS Growth Forecast (5Y) | -6.11% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CTMX has an Altman Z-Score of -1.58 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.58 |
| Piotroski F-Score | 4 |
